RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Anna Schwartz to Middle Aged

This is a "connection" page, showing publications Anna Schwartz has written about Middle Aged.
Connection Strength

1.021
  1. Trendowski MR, Kyko JM, Lusk CM, Ruterbusch JJ, Hastert TA, Harper FWK, Thompson H, Beebe-Dimmer JL, Schwartz AG. Evaluation of health behaviors and overall quality of life in younger adult African American cancer survivors. Cancer Med. 2023 01; 12(1):684-695.
    View in: PubMed
    Score: 0.077
  2. Trendowski MR, Lusk CM, Ruterbusch JJ, Seaton R, Simon MS, Greenwald MK, Harper FWK, Beebe-Dimmer JL, Schwartz AG. Chemotherapy-induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes. Cancer Med. 2021 11; 10(22):8151-8161.
    View in: PubMed
    Score: 0.074
  3. Hastert TA, McDougall JA, Strayhorn SM, Nair M, Beebe-Dimmer JL, Schwartz AG. Social needs and health-related quality of life among African American cancer survivors: Results from the Detroit Research on Cancer Survivors study. Cancer. 2021 02 01; 127(3):467-475.
    View in: PubMed
    Score: 0.069
  4. Bea JW, de Heer H', Kinslow B, Valdez L, Yazzie E, Curley P, Dalgai S, Schwartz AL. Perceptions of Cancer Causes, Prevention, and Treatment Among Navajo Cancer Survivors. J Cancer Educ. 2020 06; 35(3):493-500.
    View in: PubMed
    Score: 0.067
  5. Beebe-Dimmer JL, Ruterbusch JJ, Harper FWK, Baird TM, Finlay DG, Rundle AG, Pandolfi SS, Hastert TA, Schwartz KL, Bepler G, Simon MS, Mantey J, Abrams J, Albrecht TL, Schwartz AG. Physical activity and quality of life in African American cancer survivors: The Detroit Research on Cancer Survivors study. Cancer. 2020 01 01; 126(9):1987-1994.
    View in: PubMed
    Score: 0.065
  6. Hastert TA, Banegas MP, Hamel LM, Reed AR, Baird T, Beebe-Dimmer JL, Schwartz AG. Race, financial hardship, and limiting care due to cost in a diverse cohort of cancer survivors. J Cancer Surviv. 2019 06; 13(3):429-437.
    View in: PubMed
    Score: 0.062
  7. Beebe-Dimmer JL, Albrecht TL, Baird TE, Ruterbusch JJ, Hastert T, Harper FWK, Simon MS, Abrams J, Schwartz KL, Schwartz AG. The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A Focus on Outcomes after Cancer in a Racially Diverse Patient Population. Cancer Epidemiol Biomarkers Prev. 2019 04; 28(4):666-674.
    View in: PubMed
    Score: 0.060
  8. Bea JW, de Heer HD, Valdez L, Kinslow B, Yazzie E, Lee MC, Nez P, Dalgai S, Schwartz A. Physical Activity among Navajo Cancer Survivors: A Qualitative Study. Am Indian Alsk Native Ment Health Res. 2018; 25(2):54-73.
    View in: PubMed
    Score: 0.057
  9. Schwartz AL, de Heer HD, Bea JW. Initiating Exercise Interventions to Promote Wellness in Cancer Patients and Survivors. Oncology (Williston Park). 2017 10 15; 31(10):711-7.
    View in: PubMed
    Score: 0.056
  10. Schwartz AG, Ray RM, Cote ML, Abrams J, Sokol RJ, Hendrix SL, Chen C, Chlebowski RT, Hubbell FA, Kooperberg C, Manson JE, O'Sullivan MJ, Rohan T, Stefanick ML, Wactawski-Wende J, Wakelee H, Simon MS. Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative Studies. J Thorac Oncol. 2015 Jul; 10(7):1004-13.
    View in: PubMed
    Score: 0.048
  11. Schwartz AL, Biddle-Newberry M, de Heer HD. Randomized trial of exercise and an online recovery tool to improve rehabilitation outcomes of cancer survivors. Phys Sportsmed. 2015 May; 43(2):143-9.
    View in: PubMed
    Score: 0.046
  12. Winters-Stone KM, Leo MC, Schwartz A. Exercise effects on hip bone mineral density in older, post-menopausal breast cancer survivors are age dependent. Arch Osteoporos. 2012; 7:301-6.
    View in: PubMed
    Score: 0.038
  13. Winters-Stone KM, Dobek J, Bennett JA, Nail LM, Leo MC, Schwartz A. The effect of resistance training on muscle strength and physical function in older, postmenopausal breast cancer survivors: a randomized controlled trial. J Cancer Surviv. 2012 Jun; 6(2):189-99.
    View in: PubMed
    Score: 0.037
  14. Winters-Stone KM, Dobek J, Nail L, Bennett JA, Leo MC, Naik A, Schwartz A. Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial. Breast Cancer Res Treat. 2011 Jun; 127(2):447-56.
    View in: PubMed
    Score: 0.035
  15. Schwartz AL, Winters-Stone K. Effects of a 12-month randomized controlled trial of aerobic or resistance exercise during and following cancer treatment in women. Phys Sportsmed. 2009 Oct; 37(3):62-7.
    View in: PubMed
    Score: 0.032
  16. Schwartz AL. Fatigue in long-term cancer survivors. Oncology (Williston Park). 2009 Jul; 23(8 Suppl):27, 33-4.
    View in: PubMed
    Score: 0.031
  17. Winters-Stone KM, Bennett JA, Nail L, Schwartz A. Strength, physical activity, and age predict fatigue in older breast cancer survivors. Oncol Nurs Forum. 2008 Sep; 35(5):815-21.
    View in: PubMed
    Score: 0.030
  18. Schwartz AL, Winters-Stone K, Gallucci B. Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum. 2007 May; 34(3):627-33.
    View in: PubMed
    Score: 0.027
  19. Schwartz AL. Exercise regimen reduces fatigue. Oncology (Williston Park). 2007 Apr; 21(4 Suppl):37-9.
    View in: PubMed
    Score: 0.027
  20. Schwartz AL, Thompson JA, Masood N. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum. 2002 Aug; 29(7):E85-90.
    View in: PubMed
    Score: 0.019
  21. Schwartz AL, Meek PM, Nail LM, Fargo J, Lundquist M, Donofrio M, Grainger M, Throckmorton T, Mateo M. Measurement of fatigue. determining minimally important clinical differences. J Clin Epidemiol. 2002 Mar; 55(3):239-44.
    View in: PubMed
    Score: 0.019
  22. Mills AM, Peres LC, Meiss A, Ring KL, Modesitt SC, Abbott SE, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, Terry PD, Wallace K, Schildkraut JM. Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES). Int J Gynecol Pathol. 2019 Mar; 38(2):157-170.
    View in: PubMed
    Score: 0.015
  23. Chen LS, Hung RJ, Baker T, Horton A, Culverhouse R, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kim C, Lutz S, Rosenberger A, Aben KK, Andrew AS, Breslau N, Chang SC, Dieffenbach AK, Dienemann H, Frederiksen B, Han J, Hatsukami DK, Johnson EO, Pande M, Wrensch MR, McLaughlin J, Skaug V, van der Heijden HF, Wampfler J, Wenzlaff A, Woll P, Zienolddiny S, Bickeb?ller H, Brenner H, Duell EJ, Haugen A, Heinrich J, Hokanson JE, Hunter DJ, Kiemeney LA, Lazarus P, Le Marchand L, Liu G, Mayordomo J, Risch A, Schwartz AG, Teare D, Wu X, Wiencke JK, Yang P, Zhang ZF, Spitz MR, Kraft P, Amos CI, Bierut LJ. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. J Natl Cancer Inst. 2015 May; 107(5).
    View in: PubMed
    Score: 0.012
  24. Schmitz KH, Prosnitz RG, Schwartz AL, Carver JR. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors. Cancer. 2012 Apr 15; 118(8 Suppl):2270-6.
    View in: PubMed
    Score: 0.010
  25. Berk L, James J, Schwartz A, Hug E, Mahadevan A, Samuels M, Kachnic L. A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122). Support Care Cancer. 2008 Oct; 16(10):1179-88.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support